When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AGLE - Aeglea reports positive data for pegzilarginase in ARG1-D
Aeglea BioTherapeutics Inc.
Aeglea BioTherapeutics (NASDAQ:AGLE) has presented new positive Phase 1/2 data for pegzilarginase in patients with Arginase 1 Deficiency (ARG1-D) at the 2019 SIMD meeting.
More news on: Aeglea BioTherapeutics, Inc., Healthcare stocks news,